Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term methylphenidate effects in children with ADHD
NL-OMON49265Phase 3Not yet recruiting
- Sponsor
- Accare
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of methylphenidate, sponsored by Accare. Planned start Aug 2023; status: not yet recruiting.
02
Drugs
methylphenidate
Beyond the preview
Go deeper on NL-OMON49265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49265.